| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |



*Department of Biochemistry and Molecular Biology,
Department of Medicine, and
Department of Neuroscience, University of Florida, Gainesville, Florida.
Correspondence to Dr. Anupam Agarwal, Assistant Professor of Medicine, Division of Nephrology, Hypertension, and Transplantation, Box 100224 JHMHC, 1600 SW Archer Road, University of Florida, Gainesville, FL 32610. Phone: 352-392-4008; Fax: 352-392-3581; E-mail: agarwal{at}nersp.nerdc.ufl.edu
ABSTRACT. Cisplatin is a potent chemotherapeutic agent that is used to treat many human malignancies. Unfortunately, in addition to side effects such as ototoxicity, anaphylaxis, and bone marrow suppression, a significant percentage of patients receiving cisplatin develop severe nephrotoxicity. Mitochondrial dysfunction that is mediated via the generation of reactive oxygen species has been implicated in the pathogenesis of cisplatin-induced renal injury. To address the mechanism, it was hypothesized that overexpression of antioxidant enzymes, such as mitochondria-localized manganese superoxide dismutase (MnSOD) or mitochondria-targeted catalase (mito-Cat), would be cytoprotective in cisplatin-induced cell injury. To this end, human MnSOD or a mito-Cat vector were stably transfected into human embryonic kidney 293 cells. Cells that overexpressed MnSOD exhibited significantly less cell rounding and detachment compared with both mito-Cat and vector controls after exposure to 20 µM cisplatin. Cell injury as assessed by DNA fragmentation and annexin V binding assays was significantly decreased in the cells that overexpressed MnSOD compared with vector alone and mito-Cat. In addition, elevated levels of MnSOD were strongly associated with increased clonogenic potential after cisplatin challenge. Thus, overexpression of MnSOD, and not catalase, protects against cisplatin-induced renal epithelial cell injury. These results demonstrate the importance of reactive oxygen species in the mechanism that underlies cisplatin-induced renal injury and specifically implicate the superoxide radical, and not hydrogen peroxide, as the mediator.
This article has been cited by other articles:
![]() |
C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1710 - F1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Basireddy, J. T. Lindsay, A. Agarwal, and D. F. Balkovetz Epithelial cell polarity and hypoxia influence heme oxygenase-1 expression by heme in renal epithelial cells Am J Physiol Renal Physiol, October 1, 2006; 291(4): F790 - F795. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, S.-O. Moon, W. Kim, M. J. Sung, D. H. Kim, K. P. Kang, Y. B. Jang, J. E. Lee, K. Y. Jang, S. Y. Lee, et al. Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2085 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seth, C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury J. Biol. Chem., September 2, 2005; 280(35): 31230 - 31239. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, J. D. Ferraris, Q. Cai, A. Agarwal, and M. B. Burg Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP Am J Physiol Renal Physiol, August 1, 2005; 289(2): F377 - F385. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Davis, A. S. Hearn, B. Fletcher, J. Bickford, J. E. Garcia, V. Leveque, J. A. Melendez, D. N. Silverman, J. Zucali, A. Agarwal, et al. Potent Anti-tumor Effects of an Active Site Mutant of Human Manganese-Superoxide Dismutase: EVOLUTIONARY CONSERVATION OF PRODUCT INHIBITION J. Biol. Chem., March 26, 2004; 279(13): 12769 - 12776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kitiyakara, T. Chabrashvili, Y. Chen, J. Blau, A. Karber, S. Aslam, W. J. Welch, and C. S. Wilcox Salt Intake, Oxidative Stress, and Renal Expression of NADPH Oxidase and Superoxide Dismutase J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2775 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satoh, N. Kashihara, S. Fujimoto, H. Horike, T. Tokura, T. Namikoshi, T. Sasaki, and H. Makino A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1183 - 1190. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673